Prandin is repaglinide, a tablet taken before meals for type 2 diabetes — and repaglinide is not on the Australian register. No repaglinide product is registered in Australia, so it is not approved for supply here. Read what that means below, and ask your GP about the medicines that are. Current prices are in the table above.

What is repaglinide?

Repaglinide is used for type 2 diabetes when high blood glucose cannot be controlled by diet, weight reduction and exercise; it helps the pancreas produce more insulin at mealtimes (EMA — NovoNorm (repaglinide)).

How is it taken?

Before meals, normally up to 15 minutes before each main meal (EMA — NovoNorm (repaglinide)). The dose is set by a doctor.

What are the side effects?

The most common, in between 1 and 10 people in 100, are hypoglycaemia (low blood glucose), stomach pain and diarrhoea (EMA — NovoNorm (repaglinide)).

What does "not on the ARTG" mean?

A search of the Australian Register of Therapeutic Goods for repaglinide returns no results (ARTG search). The TGA states that products not listed in the ARTG "are not approved for supply in Australia, have not been reviewed for safety or quality" (TGA). The type 2 diabetes medicines registered in Australia — metformin, sulfonylureas such as glimepiride, gliptins, SGLT2 inhibitors, GLP-1 medicines and insulin — are compared in our guide to type 2 diabetes medicines; your GP can tell you which suits you.

Delivery to Australia

Orders are dispatched from India or Hong Kong, not from an Australian warehouse. Express delivery takes 5–9 days and regular delivery 10–14 days; orders from A$320 ship free. The details are on the delivery page. The other type 2 diabetes medicines are compared in our guide to type 2 diabetes medicines.

Sources